703 related articles for article (PubMed ID: 17192947)
1. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
3. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.
Akbari RP; Paty PB; Guillem JG; Weiser MR; Temple LK; Minsky BD; Saltz L; Wong WD
Dis Colon Rectum; 2004 Jul; 47(7):1136-44. PubMed ID: 15164245
[TBL] [Abstract][Full Text] [Related]
5. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
6. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
7. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
[TBL] [Abstract][Full Text] [Related]
8. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
10. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
[TBL] [Abstract][Full Text] [Related]
12. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
14. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration.
Barber HR
Cancer Invest; 1987; 5(4):331-8. PubMed ID: 3311312
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
17. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients.
Querleu D; Leblanc E; Cartron G; Narducci F; Ferron G; Martel P
Am J Obstet Gynecol; 2006 Nov; 195(5):1287-92. PubMed ID: 16677594
[TBL] [Abstract][Full Text] [Related]
18. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.
Martínez-Monge R; Jurado M; Cambeiro M; Valero J; Villafranca E; Alcázar JL
Brachytherapy; 2006; 5(4):203-10. PubMed ID: 17118310
[TBL] [Abstract][Full Text] [Related]
19. Radical gynecologic surgery for cancer.
Hughes SH; Steller MA
Surg Oncol Clin N Am; 2005 Jul; 14(3):607-31, viii. PubMed ID: 15978432
[No Abstract] [Full Text] [Related]
20. The role of surgery in the management of recurrent gynecologic cancer.
Hogan WM; Boente MP
Semin Oncol; 1993 Oct; 20(5):462-72. PubMed ID: 7692604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
